Bellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 OverviewBellevue Life Sciences Acquisition - Tradeable Rights - Feb 2028 Total Revenue
Revenue analysis for BLACR.
Quarterly Revenue
$484057.00
↓ 36.41% YoY
As of Mar 2026
Annual Revenue (TTM)
$2.63M
↑ 245.29% YoY
Trailing 12 months ending Mar 2026
Average Revenue (Comparison Companies)
Total Revenue History
Total Revenue Comparison
Annual Revenue Growth Rate (%)
Annual Revenue Growth (Absolute)